NASDAQ: GMABGenmab A Stock Ownership - Who owns Genmab A?
Insider buying vs selling
Have Genmab A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GMAB insiders and whales buy or sell their stock.
GMAB Shareholders
What type of owners hold Genmab A stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Orbis Allan Gray Ltd | 20.12% | 12,925,578 | $368.57M | Institution |
| Alliancebernstein LP | 14.88% | 9,557,149 | $272.52M | Institution |
| Paradigm Biocapital Advisors LP | 12.40% | 7,967,836 | $227.20M | Institution |
| Arrowstreet Capital Limited Partnership | 7.74% | 4,975,324 | $141.87M | Institution |
| Blackrock Inc | 7.06% | 4,536,565 | $129.36M | Institution |
| Renaissance Technologies LLC | 6.87% | 4,414,550 | $125.88M | Institution |
| Deep Track Capital LP | 5.70% | 3,663,250 | $104.46M | Institution |
| Harding Loevner LP | 5.03% | 3,231,601 | $92.15M | Institution |
| Deerfield Management Company LP | 3.83% | 2,462,000 | $70.20M | Institution |
| First Trust Advisors LP | 3.83% | 2,461,342 | $70.19M | Institution |
GMAB vs Biotech Stocks
Genmab A Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.